Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2014

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

BIOLOGICAL

HyperAcute-Lung Cancer Vaccine

300 million cells given intradermally every 3 weeks for up to a total of 12 vaccinations

Trial Locations (2)

Northwestern University, Chicago

Washington University in St. Louis, St Louis